A Comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells

Stem Cells and Development

Volumn 18, Issue 4, 2009, Pages 545-558

  Kang, Quan ^a,b   Song, Wen Xin ^a,b   Luo, Qing ^a,b   Tang, Ni ^a   Luo, Jinyong ^a,b   Luo, Xiaoji ^a,b   Chen, Jin ^a,b   Bi, Yang ^a,b   He, Bai Cheng ^a,b   Park, Jong Kyung ^a,c   Jiang, Wei ^b   Tang, Yi ^d   Huang, Jiayi ^a,b   Su, Yuxi ^a,b   Zhu, Gao Hui ^a,b   He, Yun ^a,b   Yin, Hong ^b   Hu, Zhenming ^a   Wang, Yi ^a,b   Chen, Liang ^a   Zuo, Guo Wei ^a,b   Pan, Xiaochuan ^e   Shen, Jikun ^b   Vokes, Tamara ^f   Reid, Russell R ^b   Haydon, Rex C ^b   Luu, Hue H ^b   He, Tong Chuan ^a,b   more..

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^c The Catholic University of Korea   (South Korea)

^d CHILDREN'S MEMORIAL HOSPITAL   (United States)

^e Northwestern University Children's Memorial Hospital ^*

^f UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 6; BONE MORPHOGENETIC PROTEIN 9; MYOD PROTEIN; OSTEOGENIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX9;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL STIMULATION; CELL STRAIN HEK293; CONTROLLED STUDY; EMBRYO; EMBRYO CELL; FIBROBLAST; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MESENCHYMAL STEM CELL; MINERALIZATION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; STEM CELL TRANSPLANTATION;

ADIPOGENESIS; ANIMALS; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELL LINEAGE; CORE BINDING FACTOR ALPHA 1 SUBUNIT; GENE KNOCKDOWN TECHNIQUES; HUMANS; MALE; MESENCHYMAL STEM CELLS; MICE; MICE, KNOCKOUT; MICE, NUDE; OSTEOGENESIS; PLURIPOTENT STEM CELLS; PPAR GAMMA; PROTEIN ISOFORMS; STEM CELL TRANSPLANTATION;

MUS;

EID: 67649271549     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2008.0130     Document Type: Article

References (73)

1. Prockop DJ. (1997). Marrow stromal cells as stem cells for non- hematopoietic tissues. Science 276:71-74.
2. Aubin JE. (1998). Bone stem cells. J Cell Biochem Suppl 31:73-82.
3. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
4. Ducy P, T Schinke and G Karsenty. (2000). The osteoblast: a sophisticated fibroblast under central surveillance. Science 289:1501-1504.
5. Caplan AI and SP Bruder. (2001). Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends in Mol Med 7:259-264.
6. Friedenstein AJ, S Piatetzky, II and KV Petrakova. (1966). Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol 16:381-390.
7. Baksh D, L Song and RS Tuan. (2004). Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med 8:301-316.
8. Barry FP and JM Murphy. (2004). Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol 36:568-584.
9. Rubio D, J Garcia-Castro, MC Martin, R de la Fuente, JC Cigudosa, AC Lloyd and A Bernad. (2005). Spontaneous human adult stem cell transformation. Cancer Res 65:3035-3039.
10. Burns JS, BM Abdallah, P Guldberg, J Rygaard, HD Schroder and M Kassem. (2005). Tumorigenic heterogeneity in cancer stem cells evolved from long-term cultures of telomerase- immortalized human mesenchymal stem cells. Cancer Res 65:3126-3135.
11. Molofsky AV, R Pardal and SJ Morrison. (2004). Diverse mechanisms regulate stem cell self-renewal. Curr Opin Cell Biol 16:700-707.
12. Wang J and A Wynshaw-Boris. (2004). The canonical Wnt pathway in early mammalian embryogenesis and stem cell maintenance/differentiation. Curr Opin Genet Dev 14:533-539.
13. Kleber M and L Sommer. (2004). Wnt signaling and the regulation of stem cell function. Curr Opin Cell Biol 16:681-687
14. Reya T and H Clevers. (2005). Wnt signalling in stem cells and cancer. Nature 434:843-850.
15. Luo J, J Chen, ZL Deng, X Luo, WX Song, KA Sharff, N Tang, RC Haydon, HH Luu and TC He. (2007). Wnt signaling and human diseases: what are the therapeutic implications? Lab Invest 87:97-103.
16. Deng ZL, KA Sharff, N Tang, WX Song, J Luo, L X., J Chen, E Bennett, R Reid, D Manning, A Xue, AG Montag, HH Luu, RC Haydon and T-C He. (2008). Regulation of osteogenic differentiation during skeletal development. Frontiers in Biosci 13:2001-2021.
17. Shi Y and J Massague. (2003). Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113:685-700.
18. Attisano L and JL Wrana. (2002). Signal transduction by the TGF-beta superfamily. Science 296:1646-1647.
19. Varga AC and JL Wrana. (2005). The disparate role of BMP in stem cell biology. Oncogene 24:5713-5721.
20. Zhang J and L Li. (2005). BMP signaling and stem cell regulation. Dev Biol 284:1-11.
21. Hogan BL. (1996). Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev 10:1580-1594.
22. Luo J, MH Sun, Q Kang, Y Peng, W Jiang, HH Luu, Q Luo, JY Park, Y Li, RC Haydon and TC He. (2005). Gene therapy for bone regeneration. Curr Gene Ther 5:167-179.
23. Zhao GQ. (2003). Consequences of knocking out BMP signaling in the mouse. Genesis 35:43-56.
24. Urist MR. (1965). Bone: formation by autoinduction. Science 150:893-899.
25. Reddi AH. (1998). Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat Biotechnol 16:247-252.
26. Ducy P and G Karsenty. (2000). The family of bone morphoge- netic proteins. Kidney Int 57:2207-2214.
27. Luu HH, WX Song, X Luo, D Manning, J Luo, ZL Deng, KA Sharff, AG Montag, RC Haydon and TC He. (2007). Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells. J Orthop Res 25:665-677.
28. Cheng H, W Jiang, FM Phillips, RC Haydon, Y Peng, L Zhou, HH Luu, N An, B Breyer, P Vanichakarn, JP Szatkowski, JY Park and TC He. (2003). Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am 85-A:1544-1552.
29. Kang Q, MH Sun, H Cheng, Y Peng, AG Montag, AT Deyrup, W Jiang, HH Luu, J Luo, JP Szatkowski, P Vanichakarn, JY Park, Y Li, RC Haydon and TC He. (2004). Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther 11:1312-1320.
30. Peng Y, Q Kang, H Cheng, X Li, MH Sun, W Jiang, HH Luu, JY Park, RC Haydon and TC He. (2003). Transcriptional characterization of bone morphogenetic proteins (BMPs)-mediated oste- ogenic signaling. J Cell Biochem 90:1149-1165.
31. Peng Y, Q Kang, Q Luo, W Jiang, W Si, BA Liu, HH Luu, JK Park, X Li, J Luo, AG Montag, RC Haydon and TC He. (2004). Inhibitor of DNA binding/differentiation helix-loop-helix proteins mediate bone morphogenetic protein-induced osteoblast differentiation of mesenchymal stem cells. J Biol Chem 279:32941-32949.
32. Luo Q, Q Kang, W Si, W Jiang, JK Park, Y Peng, X Li, HH Luu, J Luo, AG Montag, RC Haydon and TC He. (2004). Connective tissue growth factor (CTGF) is regulated by Wnt and bone mor- phogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells. J Biol Chem 279:55958-55968.
33. Si W, Q Kang, HH Luu, JK Park, Q Luo, WX Song, W Jiang, X Luo, X Li, H Yin, AG Montag, RC Haydon and TC He. (2006). CCN1/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells. Mol Cell Biol 26:2955-2964.
34. Chen TL, WJ Shen and FB Kraemer. (2001). Human BMP-7/ OP-1 induces the growth and differentiation of adipocytes and osteoblasts in bone marrow stromal cell cultures. J Cell Biochem 82:187-199.
35. Gimble JM, C Morgan, K Kelly, X Wu, V Dandapani, CS Wang and V Rosen. (1995). Bone morphogenetic proteins inhibit adi- pocyte differentiation by bone marrow stromal cells. J Cell Biochem 58:393-402.
36. Ji X, D Chen, C Xu, SE Harris, GR Mundy and T Yoneda. (2000). Patterns of gene expression associated with BMP-2-induced osteoblast and adipocyte differentiation of mesenchymal progenitor cell 3T3-F442A [In Process Citation]. J Bone Miner Metab 18:132-139.
37. Sottile V and K Seuwen. (2000). Bone morphogenetic protein-2 stimulates adipogenic differentiation of mesenchymal precursor cells in synergy with BL 49653 (rosiglitazone). FEBS Lett 475:201-204.
38. Tang MK, AK Leung, WH Kwong, PH Chow, JY Chan, V Ngo- Muller, M Li and KK Lee. (2000). Bmp-4 requires the presence of the digits to initiate programmed cell death in limb interdigital tissues. Dev Biol 218:89-98.
39. Bowers RR, JW Kim, TC Otto and MD Lane. (2006). Stable stem cell commitment to the adipocyte lineage by inhibition of DNA methylation: Role of the BMP-4 gene. Proc Natl Acad Sci USA 103:13022-13027.
40. Wang EA, DI Israel, S Kelly and DP Luxenberg. (1993). Bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells. Growth Factors 9:57-71.
41. Taha MF, MR Valojerdi and SJ Mowla. (2006). Effect of bone morphogenetic protein-4 (BMP-4) on adipocyte differentiation from mouse embryonic stem cells. Anat Histol Embryol 35:271-278.
42. zur Nieden NI, G Kempka, DE Rancourt and HJ Ahr. (2005). Induction of chondro-, osteo- and adipogenesis in embryonic stem cells by bone morphogenetic protein-2: effect of cofactors on differentiating lineages. BMC Dev Biol 5:1.
43. Fux C, B Mitta, BP Kramer and M Fussenegger. (2004). Dual-regulated expression of C/EBP-alpha and BMP-2 enables differential differentiation of C2C12 cells into adipocytes and osteoblasts. Nucleic Acids Res 32:e1.
44. Mie M, H Ohgushi, Y Yanagida, T Haruyama, E Kobatake and M Aizawa. (2000). Osteogenesis coordinated in C3H10T1 /2 cells by adipogenesis-dependent BMP-2 expression system. Tissue Eng 6:9-18.
45. Asahina I, TK Sampath and PV Hauschka. (1996). Human oste- ogenic protein-1 induces chondroblastic, osteoblastic, and/or adipocytic differentiation of clonal murine target cells. Exp Cell Res 222:38-47.
46. Ahrens M, T Ankenbauer, D Schroder, A Hollnagel, H Mayer and G Gross. (1993). Expression of human bone morphogenetic proteins-2 or -4 in murine mesenchymal progenitor C3H10T1/2 cells induces differentiation into distinct mesenchymal cell lineages. DNA Cell Biol 12:871-880.
47. Reznikoff CA, DW Brankow and C Heidelberger. (1973). Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of division. Cancer Res 33:3231-3238.
48. He TC, S Zhou, LT da Costa, J Yu, KW Kinzler and B Vogelstein. (1998). A simplified system for generating recombinant adeno- viruses. Proc Natl Acad Sci USA 95:2509-2514.
49. Luo J, ZL Deng, X Luo, N Tang, WX Song, J Chen, KA Sharff, HH Luu, RC Haydon, KW Kinzler, B Vogelstein and TC He. (2007).
50. A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat Protoc 2:1236-1247
51. He TC, AB Sparks, C Rago, H Hermeking, L Zawel, LT da Costa, PJ Morin, B Vogelstein and KW Kinzler. (1998). Identification of c-MYC as a target of the APC pathway. Science 281:1509-1512.
52. He TC, TA Chan, B Vogelstein and KW Kinzler. (1999). PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99:335-345.
53. Luo Q, Q Kang, WX Song, HH Luu, X Luo, N An, J Luo, ZL Deng, W Jiang, H Yin, J Chen, KA Sharff, N Tang, E Bennett, RC Haydon and TC He. (2007). Selection and validation of optimal siRNA target sites for RNAi-mediated gene silencing. Gene 395:160-169.
54. Daluiski A, T Engstrand, ME Bahamonde, LW Gamer, E Agius, SL Stevenson, K Cox, V Rosen and KM Lyons. (2001). Bone mor- phogenetic protein-3 is a negative regulator of bone density. Nat Genet 27:84-88.
55. Li JZ, H Li, T Sasaki, D Holman, B Beres, RJ Dumont, DD Pittman, GR Hankins and GA Helm. (2003). Osteogenic potential of five different recombinant human bone morphogenetic protein adenoviral vectors in the rat. Gene Ther 10:1735-1743.
56. Meunier P, J Aaron, C Edouard and G Vignon. (1971). Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies. Clin Orthop Relat Res 80:147-154.
57. Burkhardt R, G Kettner, W Bohm, M Schmidmeier, R Schlag, B Frisch, B Mallmann, W Eisenmenger and T Gilg. (1987). Changes in trabecular bone, hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis, and old age: a comparative histomorphometric study. Bone 8:157-164.
58. Rozman C, JC Reverter, E Feliu, L Berga, M Rozman and C Climent. (1990). Variations of fat tissue fraction in abnormal human bone marrow depend both on size and number of adi- pocytes: a stereologic study. Blood 76:892-895.
59. Kajkenova O, B Lecka-Czernik, I Gubrij, SP Hauser, K Takahashi, AM Parfitt, RL Jilka, SC Manolagas and DA Lipschitz. (1997). Increased adipogenesis and myelopoiesis in the bone marrow of SAMP6, a murine model of defective osteoblastogenesis and low turnover osteopenia. J Bone Miner Res 12:1772-1779.
60. Verma S, JH Rajaratnam, J Denton, JA Hoyland and RJ Byers. (2002). Adipocytic proportion of bone marrow is inversely related to bone formation in osteoporosis. J Clin Pathol 55:693-698.
61. Justesen J, K Stenderup, EN Ebbesen, L Mosekilde, T Steiniche and M Kassem. (2001). Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology 2:165-171.
62. Nuttall ME and JM Gimble. (2004). Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications. Curr Opin Pharmacol 4:290-294.
63. Moerman EJ, K Teng, DA Lipschitz and B Lecka-Czernik. (2004). Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-gamma2 transcription factor and TGF-beta/BMP signaling pathways. Aging Cell 3:379-389.
64. Akune T, S Ohba, S Kamekura, M Yamaguchi, UI Chung, N Kubota, Y Terauchi, Y Harada, Y Azuma, K Nakamura, T Kadowaki and H Kawaguchi. (2004). PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest 113:846-855.
65. Ali AA, RS Weinstein, SA Stewart, AM Parfitt, SC Manolagas and RL Jilka. (2005). Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation. Endocrinology 146:1226-1235.
66. Soroceanu MA, D Miao, XY Bai, H Su, D Goltzman and AC Karaplis. (2004). Rosiglitazone impacts negatively on bone
67. by promoting osteoblast/osteocyte apoptosis. J Endocrinol 183:203-216.
68. Kaplan FS and EM Shore. (2000). Progressive osseous heteropla- sia. J Bone Miner Res 15:2084-2094.
69. Kobayashi H, Y Gao, C Ueta, A Yamaguchi and T Komori. (2000). Multilineage differentiation of Cbfa1-deficient calvarial cells in vitro. Biochem Biophys Res Commun 273:630-636.
70. Jin W, T Takagi, SN Kanesashi, T Kurahashi, T Nomura, J Harada and S Ishii. (2006). Schnurri-2 controls BMP-dependent adipo- genesis via interaction with Smad proteins. Dev Cell 10:461-471.
71. Muraglia A, R Cancedda and R Quarto. (2000). Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 113 (Pt 7):1161-1166.
72. Osyczka AM, U Noth, J O'Connor, EJ Caterson, K Yoon, KG Danielson and RS Tuan. (2002). Multilineage differentiation of adult human bone marrow progenitor cells transduced with human papilloma virus type 16 E6/E7 genes. Calcif Tissue Int 71:447-458.
73. Hong JH, ES Hwang, MT McManus, A Amsterdam, Y Tian, R Kalmukova, E Mueller, T Benjamin, BM Spiegelman, PA Sharp, N Hopkins and MB Yaffe. (2005). TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 309:1074-1078.